Nanozyme-E

Nanozyme-E is an early-stage therapeutic candidate being developed by Cenyx Biotech, a South Korean biotechnology company focused on the development of "nanozymes"—nanomaterials that exhibit intrinsic enzyme-like activities. Nanozymes are typically designed to mimic the function of antioxidant enzymes such as superoxide dismutase (SOD), catalase, or peroxidase to mitigate oxidative stress and inflammation. While Cenyx Biotech's lead programs target acute neurological conditions, the specific chemical composition, biological target, and therapeutic indication for Nanozyme-E are currently classified as confidential by the company.